HUE046729T2 - Mirabegront tartalmazó gyógyszerkészítmény - Google Patents
Mirabegront tartalmazó gyógyszerkészítményInfo
- Publication number
- HUE046729T2 HUE046729T2 HUE16773147A HUE16773147A HUE046729T2 HU E046729 T2 HUE046729 T2 HU E046729T2 HU E16773147 A HUE16773147 A HU E16773147A HU E16773147 A HUE16773147 A HU E16773147A HU E046729 T2 HUE046729 T2 HU E046729T2
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical composition
- composition containing
- containing mirabegron
- mirabegron
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015073911A JP2018090490A (ja) | 2015-03-31 | 2015-03-31 | ミラベグロン含有医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE046729T2 true HUE046729T2 (hu) | 2020-03-30 |
Family
ID=57005157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE16773147A HUE046729T2 (hu) | 2015-03-31 | 2016-03-31 | Mirabegront tartalmazó gyógyszerkészítmény |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10058536B2 (hu) |
| EP (1) | EP3278801B1 (hu) |
| JP (1) | JP2018090490A (hu) |
| CY (1) | CY1122352T1 (hu) |
| DK (1) | DK3278801T3 (hu) |
| ES (1) | ES2760673T3 (hu) |
| HR (1) | HRP20192213T1 (hu) |
| HU (1) | HUE046729T2 (hu) |
| LT (1) | LT3278801T (hu) |
| PL (1) | PL3278801T3 (hu) |
| PT (1) | PT3278801T (hu) |
| RS (1) | RS59626B1 (hu) |
| SI (1) | SI3278801T1 (hu) |
| WO (1) | WO2016159267A1 (hu) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6713734B2 (ja) * | 2015-07-02 | 2020-06-24 | 三栄源エフ・エフ・アイ株式会社 | 粉体組成物のダマの形成を抑制する方法 |
| WO2019167978A1 (ja) * | 2018-02-28 | 2019-09-06 | 大日本住友製薬株式会社 | 溶出が制御された水性懸濁型医薬製剤 |
| EP3760205A4 (en) * | 2018-02-28 | 2021-10-27 | Sumitomo Dainippon Pharma Co., Ltd. | AQUATIC SUSPENSION TYPE PHARMACEUTICAL PREPARATION |
| KR102067261B1 (ko) * | 2018-03-13 | 2020-01-16 | 충북대학교 산학협력단 | 미라베그론을 유효 성분으로 포함하는 서방형의 약학 조성물 및 이의 제조방법 |
| US11583521B2 (en) * | 2020-07-01 | 2023-02-21 | Jubilant Pharma Holdings Inc. | Long-acting injection dosage form of beta 3 adrenoreceptor agonists |
| US11311518B1 (en) * | 2021-06-29 | 2022-04-26 | Jubilant Pharma Holdings Inc. | Parenteral dosage form of β3 adrenoreceptor agonists |
| CN114617881A (zh) * | 2022-02-19 | 2022-06-14 | 苏州海景医药科技有限公司 | 一种米拉贝隆组合物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2985714B2 (ja) | 1995-03-20 | 1999-12-06 | 栗田工業株式会社 | 抗菌性組成物 |
| EP1028111B1 (en) | 1997-10-17 | 2004-05-12 | Yamanouchi Pharmaceutical Co. Ltd. | Amide derivatives or salts thereof |
| US6514492B1 (en) * | 1999-07-14 | 2003-02-04 | Schering-Plough Veterinary Corporation | Taste masking of oral quinolone liquid preparations using ion exchange resins |
| CA2379987A1 (en) | 1999-07-29 | 2001-02-08 | Roxane Laboratories, Inc. | Opioid sustained-released formulation |
| JP3795365B2 (ja) | 2001-09-28 | 2006-07-12 | 和光堂株式会社 | 服薬補助食品 |
| US7342117B2 (en) | 2001-10-30 | 2008-03-11 | Astellas Pharma Inc. | α-form or β-form crystal of acetanilide derivative |
| MXPA05004925A (es) * | 2002-11-07 | 2005-08-18 | Yamanouchi Pharma Co Ltd | Remedio para vejiga hiperactiva que incluye derivado de anilida de acido acetico como el ingrediente activo. |
| JP4211668B2 (ja) | 2004-04-21 | 2009-01-21 | キユーピー株式会社 | ゾル状又はゲル状食品調製用粉末組成物 |
| CN1879610A (zh) | 2006-04-03 | 2006-12-20 | 哈尔滨工业大学 | 口服多肽药物缓释微胶囊的制备方法 |
| JP3930897B1 (ja) | 2006-08-16 | 2007-06-13 | 太陽化学株式会社 | 粘度発現性を改良した増粘用組成物 |
| TWI478712B (zh) | 2008-09-30 | 2015-04-01 | Astellas Pharma Inc | 釋控性醫藥組成物 |
| WO2013147134A1 (ja) | 2012-03-30 | 2013-10-03 | アステラス製薬株式会社 | ミラベグロン含有医薬組成物 |
-
2015
- 2015-03-31 JP JP2015073911A patent/JP2018090490A/ja active Pending
-
2016
- 2016-03-31 PL PL16773147T patent/PL3278801T3/pl unknown
- 2016-03-31 ES ES16773147T patent/ES2760673T3/es active Active
- 2016-03-31 PT PT167731470T patent/PT3278801T/pt unknown
- 2016-03-31 LT LTEP16773147.0T patent/LT3278801T/lt unknown
- 2016-03-31 EP EP16773147.0A patent/EP3278801B1/en active Active
- 2016-03-31 HU HUE16773147A patent/HUE046729T2/hu unknown
- 2016-03-31 WO PCT/JP2016/060745 patent/WO2016159267A1/ja active Application Filing
- 2016-03-31 RS RS20191517A patent/RS59626B1/sr unknown
- 2016-03-31 US US15/553,107 patent/US10058536B2/en active Active
- 2016-03-31 DK DK16773147.0T patent/DK3278801T3/da active
- 2016-03-31 SI SI201630525T patent/SI3278801T1/sl unknown
-
2019
- 2019-12-04 CY CY20191101276T patent/CY1122352T1/el unknown
- 2019-12-10 HR HRP20192213TT patent/HRP20192213T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1122352T1 (el) | 2021-01-27 |
| US20180036288A1 (en) | 2018-02-08 |
| HRP20192213T1 (hr) | 2020-03-20 |
| EP3278801B1 (en) | 2019-11-13 |
| WO2016159267A1 (ja) | 2016-10-06 |
| EP3278801A4 (en) | 2018-11-14 |
| US10058536B2 (en) | 2018-08-28 |
| PT3278801T (pt) | 2019-12-18 |
| EP3278801A1 (en) | 2018-02-07 |
| DK3278801T3 (da) | 2019-12-16 |
| SI3278801T1 (sl) | 2020-01-31 |
| PL3278801T3 (pl) | 2020-03-31 |
| RS59626B1 (sr) | 2020-01-31 |
| LT3278801T (lt) | 2020-01-10 |
| ES2760673T3 (es) | 2020-05-14 |
| JP2018090490A (ja) | 2018-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL265360A (en) | Pharmaceutical composition | |
| IL265260B (en) | pharmaceutical preparations | |
| GB201409471D0 (en) | Pharmaceutical composition | |
| SG11201605366QA (en) | Pharmaceutical composition containing pyridylaminoacetic acidcompound | |
| IL262654A (en) | Pharmacy preparation | |
| IL265349A (en) | Pharmaceutical composition | |
| GB201409488D0 (en) | Pharmaceutical composition | |
| GB201409485D0 (en) | Pharmaceutical composition | |
| RS59626B1 (sr) | Farmaceutska kompozicija koja sadrži mirabegron | |
| GB201506526D0 (en) | Medicinal composition | |
| IL263040A (en) | Pharmaceutical composition comprising eteplirsen | |
| GB201521462D0 (en) | Pharmaceutical composition | |
| HK1250491A1 (zh) | 穩定化的醫藥組合物 | |
| GB201515310D0 (en) | Pharmaceutical composition | |
| HK1245073A1 (zh) | 藥物組合物 | |
| PL3454838T3 (pl) | Kompozycja farmaceutyczna | |
| GB201615917D0 (en) | Pharmaceutical composition | |
| GB201520862D0 (en) | Pharmaceutical composition | |
| GB201615910D0 (en) | Pharmaceutical composition | |
| GB201615914D0 (en) | Pharmaceutical composition | |
| HUE050881T2 (hu) | Gyógyszerkészítmény | |
| IL265436B (en) | Pharmacy preparation | |
| HUE057830T2 (hu) | Famitinib tartalmú gyógyszerkészítmény | |
| GB2529605B (en) | Pharmaceutical composition | |
| IL265428A (en) | Pharmaceutical composition |